Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Taiwan May Shoot Down Chinese Drones

Chinese drones have been spotted circling in Taiwan's restricted…
Read more

China to U.S.: Remove Sanctions on Iran

China has pressured President Biden to remove all the sanctions…
Read more

LGBTQ Activists Sue Feds to Kill ‘Religious Exemption’

Activists for the LGBTQ community are suing the Department…
Read more